Mechanisms of immune dysfunction in stem cell transplantation

James E Talmadge, Rakesh K Singh, Kazuhiko Ino, Ana Ageitos, Suleyman Buyukberber

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

High dose therapy (HDT) and stem cell transplantation (SCT) results in alterations in the immunologic network, thymic re-education and the induction of peripheral tolerance. The changes to the immunoregulatory cascade and tolerance induction associated with autotransplants have been investigated in a series of studies focused on leukocyte reconstitution and function following HDT and autologous SCT. In these studies, we observed a significant decrease in the CD4:CD8 T cell ratio post-transplantation compared to normal peripheral blood (PB) donors due to a decrease in CD4+ cells. In addition, T cell function (phytohemagglutinin (PHA) mitogenesis) was consistently depressed compared to samples obtained from normal PB donors. The loss of T cell function was associated with an increased frequency of circulating monocytes, their expression of Fas ligand (FasL) and a high frequency of apoptotic CD4+ T cells. Indeed, 28-51% of circulating CD4+ T cells were observed to be apoptotic during the first 100 days following HDT and SCT. These studies suggest that 'primed' or activated Fas+ CD4+ lymphocytes interact with FasL+ monocytes, resulting in apoptosis, leading to the preferential deletion of CD4+ T cells, a decrease in the CD4:CD8 T cell ratio and depressed T cell function. Further, as discussed herein, the T cells are activated with a predominantly type 2 phenotype, which may also contribute to the maintenance of the immunosuppressive condition. Therefore, there is the potential to regulate immune recovery by stem cell product manipulation or post-transplantation cytokine administration.

Original languageEnglish (US)
Pages (from-to)1041-1056
Number of pages16
JournalInternational Journal of Immunopharmacology
Volume22
Issue number12
DOIs
StatePublished - Dec 1 2000

Fingerprint

Stem Cell Transplantation
T-Lymphocytes
Fas Ligand Protein
Blood Donors
Monocytes
Transplantation
Peripheral Tolerance
Autografts
Phytohemagglutinins
Immunosuppressive Agents
Leukocytes
Stem Cells
Therapeutics
Maintenance
Lymphocytes
Apoptosis
Cytokines
Phenotype
Education

Keywords

  • Immune regulation
  • Peripheral tolerance
  • T cell function

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Mechanisms of immune dysfunction in stem cell transplantation. / Talmadge, James E; Singh, Rakesh K; Ino, Kazuhiko; Ageitos, Ana; Buyukberber, Suleyman.

In: International Journal of Immunopharmacology, Vol. 22, No. 12, 01.12.2000, p. 1041-1056.

Research output: Contribution to journalArticle

Talmadge, James E ; Singh, Rakesh K ; Ino, Kazuhiko ; Ageitos, Ana ; Buyukberber, Suleyman. / Mechanisms of immune dysfunction in stem cell transplantation. In: International Journal of Immunopharmacology. 2000 ; Vol. 22, No. 12. pp. 1041-1056.
@article{5f943377082d474ba4fa36c7a7e335fb,
title = "Mechanisms of immune dysfunction in stem cell transplantation",
abstract = "High dose therapy (HDT) and stem cell transplantation (SCT) results in alterations in the immunologic network, thymic re-education and the induction of peripheral tolerance. The changes to the immunoregulatory cascade and tolerance induction associated with autotransplants have been investigated in a series of studies focused on leukocyte reconstitution and function following HDT and autologous SCT. In these studies, we observed a significant decrease in the CD4:CD8 T cell ratio post-transplantation compared to normal peripheral blood (PB) donors due to a decrease in CD4+ cells. In addition, T cell function (phytohemagglutinin (PHA) mitogenesis) was consistently depressed compared to samples obtained from normal PB donors. The loss of T cell function was associated with an increased frequency of circulating monocytes, their expression of Fas ligand (FasL) and a high frequency of apoptotic CD4+ T cells. Indeed, 28-51{\%} of circulating CD4+ T cells were observed to be apoptotic during the first 100 days following HDT and SCT. These studies suggest that 'primed' or activated Fas+ CD4+ lymphocytes interact with FasL+ monocytes, resulting in apoptosis, leading to the preferential deletion of CD4+ T cells, a decrease in the CD4:CD8 T cell ratio and depressed T cell function. Further, as discussed herein, the T cells are activated with a predominantly type 2 phenotype, which may also contribute to the maintenance of the immunosuppressive condition. Therefore, there is the potential to regulate immune recovery by stem cell product manipulation or post-transplantation cytokine administration.",
keywords = "Immune regulation, Peripheral tolerance, T cell function",
author = "Talmadge, {James E} and Singh, {Rakesh K} and Kazuhiko Ino and Ana Ageitos and Suleyman Buyukberber",
year = "2000",
month = "12",
day = "1",
doi = "10.1016/S0192-0561(00)00078-3",
language = "English (US)",
volume = "22",
pages = "1041--1056",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Mechanisms of immune dysfunction in stem cell transplantation

AU - Talmadge, James E

AU - Singh, Rakesh K

AU - Ino, Kazuhiko

AU - Ageitos, Ana

AU - Buyukberber, Suleyman

PY - 2000/12/1

Y1 - 2000/12/1

N2 - High dose therapy (HDT) and stem cell transplantation (SCT) results in alterations in the immunologic network, thymic re-education and the induction of peripheral tolerance. The changes to the immunoregulatory cascade and tolerance induction associated with autotransplants have been investigated in a series of studies focused on leukocyte reconstitution and function following HDT and autologous SCT. In these studies, we observed a significant decrease in the CD4:CD8 T cell ratio post-transplantation compared to normal peripheral blood (PB) donors due to a decrease in CD4+ cells. In addition, T cell function (phytohemagglutinin (PHA) mitogenesis) was consistently depressed compared to samples obtained from normal PB donors. The loss of T cell function was associated with an increased frequency of circulating monocytes, their expression of Fas ligand (FasL) and a high frequency of apoptotic CD4+ T cells. Indeed, 28-51% of circulating CD4+ T cells were observed to be apoptotic during the first 100 days following HDT and SCT. These studies suggest that 'primed' or activated Fas+ CD4+ lymphocytes interact with FasL+ monocytes, resulting in apoptosis, leading to the preferential deletion of CD4+ T cells, a decrease in the CD4:CD8 T cell ratio and depressed T cell function. Further, as discussed herein, the T cells are activated with a predominantly type 2 phenotype, which may also contribute to the maintenance of the immunosuppressive condition. Therefore, there is the potential to regulate immune recovery by stem cell product manipulation or post-transplantation cytokine administration.

AB - High dose therapy (HDT) and stem cell transplantation (SCT) results in alterations in the immunologic network, thymic re-education and the induction of peripheral tolerance. The changes to the immunoregulatory cascade and tolerance induction associated with autotransplants have been investigated in a series of studies focused on leukocyte reconstitution and function following HDT and autologous SCT. In these studies, we observed a significant decrease in the CD4:CD8 T cell ratio post-transplantation compared to normal peripheral blood (PB) donors due to a decrease in CD4+ cells. In addition, T cell function (phytohemagglutinin (PHA) mitogenesis) was consistently depressed compared to samples obtained from normal PB donors. The loss of T cell function was associated with an increased frequency of circulating monocytes, their expression of Fas ligand (FasL) and a high frequency of apoptotic CD4+ T cells. Indeed, 28-51% of circulating CD4+ T cells were observed to be apoptotic during the first 100 days following HDT and SCT. These studies suggest that 'primed' or activated Fas+ CD4+ lymphocytes interact with FasL+ monocytes, resulting in apoptosis, leading to the preferential deletion of CD4+ T cells, a decrease in the CD4:CD8 T cell ratio and depressed T cell function. Further, as discussed herein, the T cells are activated with a predominantly type 2 phenotype, which may also contribute to the maintenance of the immunosuppressive condition. Therefore, there is the potential to regulate immune recovery by stem cell product manipulation or post-transplantation cytokine administration.

KW - Immune regulation

KW - Peripheral tolerance

KW - T cell function

UR - http://www.scopus.com/inward/record.url?scp=0034537473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034537473&partnerID=8YFLogxK

U2 - 10.1016/S0192-0561(00)00078-3

DO - 10.1016/S0192-0561(00)00078-3

M3 - Article

VL - 22

SP - 1041

EP - 1056

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 12

ER -